{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:28Z","timestamp":1787070928691,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Radical surgery for cervical cancer has inherent benefits, and as upfront or post neoadjuvant chemotherapy (NACT), is extendable to locally advanced cancer cervix (LACC), with postoperative radiotherapy (PORT) for high-risk factors. Objective of the study was to compare the effectiveness and survival between non-PORT and PORT in high-risk early stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>Radical hysterectomies conducted between January 2014 and December 2017 were evaluated and followed till December 2019. Clinical, surgical\u2013pathologic characteristics, and oncological outcomes were compared between non-PORT and PORT groups. A similar comparison was made between alive and dead patients within each group. The impact of PORT was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 178 radical surgeries, early-LACC constituted 70%. Most (37%) of the patients belonged to stage 1b2, while stage 2b formed 5%. Mean age of patients was 46.5 years; 69% were below 50 years of age. Abnormal bleeding (41%) was the predominant symptom, followed by postcoital (20%) and postmenopausal bleeding (12%). Upfront surgeries formed 70.2%, and the average waiting period was 1.93 months (range: 1\u201310 months). PORT patients were 97 (54.5%) in number and the remaining formed the non-PORT group. Mean follow-up was 34 months, with 118 (66%) alive patients. Significant adverse prognostic factors were tumors &gt;4 cm (44.4% patients), positive margins (10%), lymphatic vascular space invasion (LVSI; 42%), malignant nodes (33%), multiple metastatic nodes averaging seven (range: 3\u201311), and delayed (&gt;6 months) presentation, but not deep stromal invasion (77% patients) and positive parametrium (8.4% patients). PORT overcame the adverse effects of tumors &gt;4 cm, multiple metastatic nodes, positive margins, and LVSI. Total recurrences (25%) were balanced for both groups, but recurrences within 2 years were significantly more for PORT. Two-year overall survival (78%) and recurrence-free survival (72%), median overall survival (21 months), and median recurrence-free interval (19 months) were significantly better for PORT, with the complication rates being similar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>PORT had significantly better oncological outcomes compared to non-PORT. Multimodal management is worthwhile.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_253_22","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T07:20:24Z","timestamp":1666855224000},"page":"241-252","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Is postoperative radiotherapy (PORT) a viable option in high-risk early-stage cervical cancer after upfront or downstaged radical surgery? A comparative study"],"prefix":"10.4103","volume":"19","author":[{"given":"Viniita Kumar","family":"Jaggi","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Division of Gynecological Oncology, Delhi State Cancer Institute (GNCT of Delhi), Dilshad Garden, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Ansari","sequence":"additional","affiliation":[{"name":"Molecular Oncology Department, Delhi State Cancer Institute (GNCT of Delhi), Dilshad Garden, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Khanna","sequence":"additional","affiliation":[{"name":"Surgical Gynecological Oncology, Delhi State Cancer Institute (GNCT of Delhi), Dilshad Garden, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameep","family":"Gehlot","sequence":"additional","affiliation":[{"name":"Molecular Oncology Department, Delhi State Cancer Institute (GNCT of Delhi), Dilshad Garden, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sharma","sequence":"additional","affiliation":[{"name":"ICMR-National Institute for Implementation Research in Non-Communicable Diseases, New Pali Rd, Air Force Area, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College (MAMC), Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/1097-0142(19920115)69:2<482::AID-CNCR2820690235>3.0.CO;2-8","article-title":"A reappraisal of the International Federation of Gynecology and Obstetrics staging system for cervical cancer. A study of patterns of care","volume":"69","author":"Lanciano","year":"1992","journal-title":"Cancer"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical Cancer, Version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Koh","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/IGC.0000000000001323","article-title":"Rising rates of upfront surgery in early locally advanced cervical cancer: What factors predict for this treatment paradigm?","volume":"28","author":"Amini","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R7-20241021","journal-title":"NCCN Guidelines version 4: Cervical cancer. National Comprehensive Cancer Network"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.3802\/jgo.2018.29.e41","article-title":"Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer","volume":"29","author":"Ditto","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-018-1351-y","article-title":"Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer","volume":"24","author":"Ebina","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"R10-20241021","first-page":"169","article-title":"The extended abdominal operation for carcinoma uteri (based on 500 operative cases)","volume":"66","author":"Wertheim","year":"1912","journal-title":"Am J Obstet Gynecol Dis Women Child"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0950-3552(98)80022-9","article-title":"An improved radical hysterectomy with fewer urological complications and with no loss of therapeutic results for invasive cervical cancer","volume":"2","author":"Sakamoto","year":"1988","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IGC.0000000000000880","article-title":"Long-Term morbidity and quality of life in cervical cancer survivors: A multicenter comparison between surgery and radiotherapy as primary treatment","volume":"27","author":"Derks","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0090-8258(89)90070-X","article-title":"A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group Study","volume":"35","author":"Delgado","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"e204307","DOI":"10.1001\/jamanetworkopen.2020.4307","article-title":"Oncological outcomes after Okabayashi-Kobayashi radical hysterectomy for early and locally advanced cervical cancer","volume":"3","author":"Sakuragi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/gyno.1996.0327","article-title":"An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: A Gynecologic Oncology Group study","volume":"63","author":"Look","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/cncr.11371","article-title":"Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma","volume":"97","author":"Farley","year":"2003","journal-title":"Cancer"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0360-3016(96)00560-3","article-title":"A Postoperative radiation for cervical cancer with pathologic risk factors","volume":"37","author":"Hart","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-20241021","first-page":"569","article-title":"Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix","volume":"66","author":"Gauthier","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0090-8258(80)90068-2","article-title":"Selective radiation therapy in stage IB uterine cervical carcinoma following radical pelvic surgery","volume":"10","author":"Abdulhayoglu","year":"1980","journal-title":"Gynecol Oncol"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9378(98)80018-5","article-title":"Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival","volume":"178","author":"Obermair","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0090-8258(82)90026-9","article-title":"Histological criteria for the prognosis in patients with operated squamous cell carcinoma of the cervix","volume":"13","author":"Baltzer","year":"1982","journal-title":"Gynecol Oncol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0090-8258(82)90024-5","article-title":"Lymph node metastases from carcinoma of the cervix, stages IB and IIA: Implications for prognosis and treatment","volume":"13","author":"Fuller","year":"1982","journal-title":"Gynecol Oncol"},{"issue":"suppl 15","key":"R24-20241021","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1200\/JCO.2019.37.15_suppl.5503","article-title":"Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage 1b2-2B cervical cancer, EORTC 55994","volume":"37","author":"Kenter","year":"2019","journal-title":"J Clin Oncol"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2009.03.026","article-title":"Radical hysterectomy for FIGO stage IIB cervical cancer: Clinicopathological characteristics and prognostic evaluation","volume":"114","author":"Kasamatsu","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/COC.0b013e3181cae5b7","article-title":"Comparison between conventional surgery plus postoperative adjuvant radiotherapy and concurrent chemoradiation for FIGO stage IIB cervical carcinoma: A retrospective study","volume":"33","author":"Yamashita","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"e0221946","DOI":"10.1371\/journal.pone.0221946","article-title":"Effect of time interval from diagnosis to treatment for cervical cancer on survival: A nationwide cohort study","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/IJWH.S298204","article-title":"Timelines to Cervical Cancer Diagnosis and Treatment at a Tertiary Hospital in Botswana","volume":"13","author":"Nassali","year":"2021","journal-title":"Int J Womens Health"},{"key":"R30-20241021","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ijgc-2021-002921","article-title":"Concerv: A prospective trial of conservative surgery for low-risk early-stage cervical cancer","volume":"31","author":"Schmeler","year":"2021","journal-title":"Int J Gynecol Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_253_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:04Z","timestamp":1787067544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_253_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_253_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"2022-01-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}